Kamada (KMDA) Q1 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 05/13/26
Kamada Reports First Quarter 2026 Financial Results and Affirms 2026 Annual Guidance; Expecting Significantly Stronger Remainder of the YearGlobeNewsWire • 05/13/26
Stay Ahead of the Game With Kamada (KMDA) Q1 Earnings: Wall Street's Insights on Key MetricsZacks Investment Research • 05/08/26
Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, TexasGlobeNewsWire • 03/26/26
Kamada (KMDA) Q4 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 03/11/26
Kamada Reports Record Top- and Bottom-line 2025 Financial Results and Affirms 2026 Guidance Representing Continued Double-Digit Organic Profitable GrowthGlobeNewsWire • 03/11/26
Kamada Declares Cash Dividend of $0.25 Per Share, to be Paid in Accordance with an Adopted Annual Cash Dividend PolicyGlobeNewsWire • 03/11/26
Ahead of Kamada (KMDA) Q4 Earnings: Get Ready With Wall Street Estimates for Key MetricsZacks Investment Research • 03/06/26
Kamada Ltd. (KMDA) Discusses Discontinuation of Phase 3 Inhaled AAT Clinical Trial and Financial Outlook TranscriptSeeking Alpha • 12/08/25
Kamada (KMDA) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks Investment Research • 11/10/25
Kamada Reports Strong Third Quarter and Nine Month 2025 Financial Results with over 30% Year-over-Year Profitability GrowthGlobeNewsWire • 11/10/25
Countdown to Kamada (KMDA) Q3 Earnings: A Look at Estimates Beyond Revenue and EPSZacks Investment Research • 11/06/25
Kamada to Announce Third Quarter and Nine Months Ended September 30, 2025 Financial Results on November 10, 2025GlobeNewsWire • 11/03/25